Discover

News & Info

Trade

LongbridgeAI

Quote List Quote List

INNOGEN-B(02591.HK)

Event Tracking

Apr6

Sinorx Biopharma Commercializes Isuglugrel

12:15

Mar23

Sinono Pharmaceuticals Announces 2025 Annual Results with Expanded Losses

17:15

INNOGEN-B released FY2024 Q3 earnings on March 23 (BJT), actual revenue HKD 0, actual EPS HKD -0.1311

15:00

INNOGEN-B released FY2024 Q4 earnings on March 23 (BJT), actual revenue HKD 0, actual EPS HKD -0.1258

15:00

INNOGEN-B released FY2025 Q3 earnings on March 23, 2026 (BJT), actual revenue HKD 41.03 M, actual EPS HKD -0.2671

15:00

INNOGEN-B released FY2025 9 Months Earnings on March 23 Post-Market (BJT), actual revenue HKD 102.15 M, actual EPS HKD -0.5826

15:00

Schedules & Filings

Schedules

Filings

Mar23

Earning Release(CST)

FY2025 Q4 Earning Release (HKD) Revenue 41.74 M, Net Income -121.71 M, EPS -0.2717

Aug29

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 30.89 M, Net Income -67.02 M, EPS -0.1594

Aug15

IPO(CST)

Listing Price HKD 18.68

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

INNOGEN-B(02591.HK)

INNOGEN-B Stock Performance Chart